OSC use in asthma, TSANZ position paper 2021

OCS are frequently used in asthma in both acute (flare-ups) and chronic disease (severe asthma), despite the emergence of new treatments. OCS prescribing remains embedded in patient care.

Long-term or maintenance OCS is used in 20-60% of uncontrolled or severe asthma.

OCS inappropriate use frequently occurs in people with mild-moderate asthma that is poorly controlled due to poor adherence to or underuse of inhaled corticosteroid (ICS) therapy.

Download a copy here: Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand – PMC